Trending...
- From Robinhood to APT Miner: New Passive Income Opportunities in the Digital Asset Era - 121
- Governor Newsom provides eligible homeowners $20,000 through new CalAssist Mortgage Fund for California disaster survivors - 102
- California: Governor Newsom statement on court ruling restoring AmeriCorps funding - 102
SACRAMENTO, Calif. - Californer -- The ROS1ders, a global group of patients and caregivers living with ROS1+ cancer, announced the recipients of the 2024 ROS1+ Cancer Innovation Award. Funds for the awards were raised through individual contributions to The ROS1ders by patients and supporters. Each award carries a one-year, $75,000 seed grant to fund high-risk, high-reward research projects in ROS1+ cancer.
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
More on The Californer
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
More on The Californer
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
- Monte Winslow, PhD, Dmitri A. Petrov, PhD and Joel Neal, MD, PhD, Stanford University School of Medicine – Towards precision medicine for oncogenic ROS1 fusion driven lung cancer
This project will create models of each known ROS1 fusion variant and investigate how they influence cancer development and treatment responses. - Jaime Schneider, MD, PhD, Massachusetts General Hospital – Identifying Metabolic Vulnerabilities in ROS1+ Lung Cancer
This project aims to shed light on metabolic pathways that may contribute to acquired resistance to treatments for ROS1+ cancer, with the goal of identifying new targets for treatments that may prevent or treat resistance mechanisms.
More on The Californer
- Mental Health Watchdog Calls Baker Acting of Children in Florida a Parental Rights Violation
- AI-Designed Waveguides Pave the Way for Next-Generation Photonic Devices
- California: Governor Gavin Newsom on speaking out peacefully
- Governor Gavin Newsom on the federal government taking over the California National Guard
- California: Governor Gavin Newsom on deploying CHP to Los Angeles
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer. The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer, but few other cancers, yet.
- Patients typically have adenocarcinoma NSCLC, a younger age than the average NSCLC patient, and no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+ NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
More on The Californer
- RimoVision Group Presents the World Premiere of "Butterflies, Lies, and Alibis"
- Bridgett Brumbaugh Makes Podium at IBJJF World Championship, Signals Rise of New Talent in Wome
- Injured While Using Rideshare?
- Wealthywet's Miami Swim Week 2025 Debut Signals a New Era of Luxury in Swimwear
- Luxury Waterfront Home in Porto Sol Community Now Available Through Innovative "Name Your Price" Approach
Source: The ROS1ders, Inc.
0 Comments
Latest on The Californer
- $77.8 Million in Revenue Through April 2025, Confirms Full-Year Guidance; Fast-Track to 400 Million Run Rate; $1 Billion Target After Key Acquisition
- IFC Advisors Chooses the AdvisorVault 17a-4 Managed 365 Service®
- A. N. Publishing Releases The Debut Media Kit For 'The Ambony'
- AIRSED Launches Revolutionary AI-Driven Financial Analysis Platform, Democratizing Elite Investment Tools for Global Markets
- Bertram Sanders Jr. Earns Best Television Script at Prestigious LA Film Awards
- PACE Awarded $1.9M to Expand Early Childhood Education Workforce in Los Angeles
- Long Beach Parks to Offer Free Summer Food Service Program for Children and Youth June 16 through August 22
- TCVN Startup Pitch Competition at OC Innovation Week - Survivor™ XI Crowns FemTech Founders
- Real Estate CEO Launches Explosive New Book After $275,784 Wire Fraud Incident
- Long Beach: City Launches Community Roadshows to Engage Residents on Citywide Efforts to Address Homelessness
- TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy
- California: Governor Newsom joins Compton students to announce the Golden State Literacy Plan and deployment of literacy coaches statewide
- No Limits Method Revolutionizes Neurodivergent Education Through Embodied Cognition
- Long Beach Recognizing Pet Preparedness Month with Series of Community Events Throughout June
- Manhattan Boutique Real Estate Collaborates with InterContinental Hotels NYC in a Branding Partners Personalized Approach
- City of Long Beach Launches Community Survey for the Open Space and Recreation Element
- BRIJ Medical Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort
- First AI Marketing Platform Built Specifically for Small Businesses Launches Public Beta
- Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado
- California: Governor Newsom statement on court ruling restoring AmeriCorps funding